John L. Marshall, M.D., discusses highlights of the European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2023 and the latest advancements in colorectal cancer treatment.
EP. 1: Health-Related Quality of Life Outcomes in Metastatic Colorectal Cancer: Takeaways from the SUNLIGHT Study
John L. Marshall M.D., shares insights on health-related quality of life (HRQoL) findings from SUNLIGHT study presented at ESMO World Congress on Gastrointestinal Cancer (ESMO GI) 2023.
EP. 2: Maximizing Patient Quality of Life through Shared Decision Making in Metastatic Colorectal Cancer
Discussion on shared decision making with patients with later stage refractory metastatic colorectal cancer as well as maximizing a patient's quality of life.
EP. 3: Impact of Microsatellite Stability in Metastatic Colorectal Cancer
Dr Marshall describes the impacts of microsatellite stability and instability on metastatic colorectal cancer.
EP. 4: Botensilimab and Balstilimab in Refractory Microsatellite Stable (MSS) mCRC
An overview of data presented at ESMO GI 2023 on combined botensilimab and balstilimab therapy in heavily pretreated patients with microsatellite stable metastatic colorectal cancer.
EP. 5: Development Challenges in Microsatellite Stable mCRC
Dr Marshall discusses challenges associated with microsatellite stable metastatic colorectal cancer.
EP. 6: LEAP-017: Lenvatinib and Pembrolizumab in MSS mCRC
The LEAP-017 trial results presented at ESMO GI 2023 are explored by Dr Marshall.
EP. 7: Innovations Needed in GI Cancer and Key Takeaways from ESMO 2023
John L. Marshall M.D., explains the importance of in-person conferences and the future of AI in the field.
2 Clarke Drive Cranbury, NJ 08512